Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes

BackgroundThere is accumulating data that acute coronary syndromes relate to recent onset activation of inflammation affecting atherosclerotic plaques. Increased blood levels of oxidized low density lipoprotein (ox-LDL) could play a role in these circumstances. Methods and ResultsOx-LDL levels were measured in 135 patients with acute myocardial infarction (AMI; n=45), unstable angina pectoris (UAP; n=45), and stable angina pectoris (SAP; n=45) and in 46 control subjects using a sandwich ELISA method. In addition, 33 atherectomy specimens obtained from a different cohort of patients with SAP (n=10) and UAP (n=23) were studied immunohistochemically for ox-LDL. In AMI patients, ox-LDL levels were significantly higher than in patients with UAP (P <0.0005) or SAP (P <0.0001) or in controls (P <0.0001) (AMI, 1.95±1.42 ng/5 &mgr;g LDL protein; UAP, 1.19±0.74 ng/5 &mgr;g LDL protein; SAP, 0.89±0.48 ng/5 &mgr;g LDL protein; control, 0.58±0.23 ng/5 &mgr;g LDL protein). Serum levels of total, HDL, and LDL cholesterol did not differ among these patient groups. In the atherectomy specimens, the surface area containing ox-LDL–positive macrophages was significantly higher in patients with UAP than in those with SAP (P <0.0001). ConclusionsThis study demonstrates that ox-LDL levels show a significant positive correlation with the severity of acute coronary syndromes and that the more severe lesions also contain a significantly higher percentage of ox-LDL–positive macrophages. These observations suggest that increased levels of ox-LDL relate to plaque instability in human coronary atherosclerotic lesions.

[1]  F. Werf,et al.  Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. , 1998, Circulation.

[2]  K. Koch,et al.  Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes , 1998, Heart.

[3]  D. Collen,et al.  Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[4]  Wei Sha,et al.  Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.

[5]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[6]  M. Eldar,et al.  Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. , 1996, Heart.

[7]  Y. Hata,et al.  Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. , 1996, Journal of lipid research.

[8]  D. Collen,et al.  Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. , 1995, The Journal of clinical investigation.

[9]  D. Collen,et al.  Oxidized lipoproteins in atherosclerosis and thrombosis , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  V. Fuster,et al.  Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.

[11]  E. Anggard,et al.  Oxidative modification of low-density lipoprotein by human polymorphonuclear leucocytes to a form recognised by the lipoprotein scavenger pathway. , 1994, Biochimica et biophysica acta.

[12]  Y. Yoshida,et al.  A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. , 1994, The Journal of biological chemistry.

[13]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[14]  The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) , 1993, Archives of internal medicine.

[15]  D. Leake,et al.  The oxidative modification of low density lipoprotein by human lymphocytes. , 1992, Atherosclerosis.

[16]  E. Braunwald,et al.  Unstable angina. A classification. , 1989, Circulation.

[17]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[18]  D. Steinberg,et al.  Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.